Omega welcomes the news that Mologic Ltd has received CE Mark for its professional-use COVID-19 Rapid Antigen Test.

In June this year, Omega signed a material transfer agreement with Mologic providing access to raw materials and know-how to manufacture their lateral flow antigen test. The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs.

Read the full RNS here